The largest database of trusted experimental protocols

Recombinant shh n terminal peptide

Manufactured by R&D Systems

Recombinant SHH N-terminal peptide is a laboratory product that contains the N-terminal region of the Sonic Hedgehog (SHH) protein. SHH is a signaling protein involved in embryonic development and cell differentiation. The Recombinant SHH N-terminal peptide can be used in various research and experimental applications.

Automatically generated - may contain errors

2 protocols using recombinant shh n terminal peptide

1

Isolation and culture of primordial germ cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dissected GR tissues of E10.5 embryos were digested in 0.25% trypsin, passed through a 0.4 μm cell strainer and suspended in DMEM/L-15 medium supplemented with 20% knockout serum replacement (Invitrogen), 2 mM l-glutamine, 0.1 mM non-essential amino acids and 0.1 mM 2-mercaptoethanol (Sigma-Aldrich), before being plated onto 0.1% gelatin-coated cover slips. Cells were incubated in 0.5% serum-containing media before treatment with 200 ng/mL recombinant SHH N-terminal peptide (R&D Systems, 1314-SH) diluted in dimethyl formamide (DMF).
For PGC co-cultures with feeder layers, single-cell suspensions generated from dissected GR tissues were plated onto the NIH3T3/Cas9 feeder layer pre-treated with Mitomycin-C (5 μg/ml). The proliferation and motility of PGCs were measured by time-lapse imaging of GFP-positive cells captured every 15 min for 10 h. Live imaging was performed using Nikon A1R laser scanning confocal microscope in a humidified 5% CO2 chamber at 37.0 ± 0.5 °C. Random motility of PGC was analyzed using the Chemotaxis and Migration Tool 2.0 plug-in software (Ibidi GmbH).
+ Open protocol
+ Expand
2

Modulating Hedgehog Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ODC inhibitor DFMO (Sigma, 5mM) and putrescine (Sigma, 10μM) were added to the medium for the indicated times.
For SAG treatment, NIH3T3 cells were incubated in low serum (0.5% BS) overnight. MEF WT and Itf88−/− were incubated in 1% BSA overnight, and then exposed to SAG (200nM, Enzo Life Sciences) or KAAD (0.1 μM, Calbiochem) for the indicated times. MEF Sufu−/− and HEK293T cells were treated with MG132 (50μM, Sigma) for 6 hours. MEFs cells were treated for the indicated times with 100 μg/mL protein-synthesis inhibitor cycloheximide (CHX) (Sigma). GCPs were treated with recombinant Shh-N-terminal peptide (R&D Systems, 3 μg/ml in BSA), with KAAD (0.1μM, Calbiochem), A769662 (25μM, Santa Cruz Biotechnology), for the indicated times.
MEF cells and GCPs were pretreated with Compound C (20μM, Millipore) for 20 minutes and then stimulated with SAG or Shh, respectively, for the indicated times. For polyamine quantitation, MEF Ptch−/− and GCPs were treated with 10μM CC for 24 hours (Teperino et al., 2012 (link)). Primary medulloblastoma cells were treated with KAAD (0.5 μM) for the indicated times.
TC-71 cells were treated with 5mM DFMO (Sigma) or 5 μM arsenic trioxide (ATO, Sigma) for the indicated times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!